Lung organoids derived from adult stem cells or iPSCs model respiratory diseases including COPD, cystic fibrosis, and COVID-19. These 3D structures contain airway epithelium with ciliated cells, goblet cells, and basal cells for drug screening and viral infection studies.
COVID-19
Viral Infection Models
Lung organoids express ACE2 receptors enabling SARS-CoV-2 infection studies and antiviral screening.
COPD
Chronic Disease
Patient-derived models recapitulate emphysema and chronic bronchitis phenotypes.